{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:31:54Z","timestamp":1756189914884,"version":"3.41.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1097\/tp.0000000000001967","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T22:07:43Z","timestamp":1506722863000},"page":"e18-e25","source":"Crossref","is-referenced-by-count":4,"title":["Marked Decrease in Urgent Listing for Liver Transplantation Over Time"],"prefix":"10.1097","volume":"102","author":[{"given":"Linda L.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung P.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Seto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Lacar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willscott E.","family":"Naugler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210211","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1111\/ajt.13823","article-title":"National outcomes of liver transplantation for model for end-stage liver disease score \u226540: the impact of share 35","volume":"16","author":"Nekrasov","year":"2016","journal-title":"Am J Transplant"},{"key":"R2-18-20210211","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.13500","article-title":"One size does not fit all\u2014regional variation in the impact of the share 35 liver allocation policy","volume":"16","author":"Halazun","year":"2016","journal-title":"Am J Transplant"},{"key":"R3-18-20210211","first-page":"65","article-title":"Liver transplantation in the MELD eraanalysis of the OPTNUNOS registry.","volume":"41-","author":"Taniguchi","year":"2012","journal-title":"Clin Transpl"},{"key":"R4-18-20210211","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/TP.0b013e3181b26807","article-title":"Survival benefit after liver transplantation: a single European center experience","volume":"88","author":"Ravaioli","year":"2009","journal-title":"Transplantation"},{"key":"R5-18-20210211","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/lt.20721","article-title":"MELD and prediction of post-liver transplantation survival","volume":"12","author":"Habib","year":"2006","journal-title":"Liver Transpl"},{"key":"R8-18-20210211","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hep.27283","article-title":"Excellent Mortality on the Liver Transplant Waiting list: unintended policy consequences and model for end-stage liver disease (MELD) inflation","volume":"61","author":"Northrup","year":"2015","journal-title":"Hepatology"},{"key":"R9-18-20210211","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s12072-016-9735-4","article-title":"End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to status 1A patients","volume":"10","author":"Ahn","year":"2016","journal-title":"Hepatol Int"},{"key":"R10-18-20210211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.24632","article-title":"End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates","volume":"55","author":"Sharma","year":"2012","journal-title":"Hepatology"},{"key":"R11-18-20210211","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/apt.13943","article-title":"Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study)","volume":"45","author":"Donnelly","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-18-20210211","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Intern Med"},{"key":"R13-18-20210211","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/ajt.14126","article-title":"OPTN\/SRTR 2015 Annual Data Report: liver","volume":"17","author":"Kim","year":"2017","journal-title":"Am J Transplant"},{"key":"R14-18-20210211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7863\/jum.2001.20.1.51","article-title":"Early detection of hepatic artery thrombosis after LT by Doppler ultrasonography: prognostic implications","volume":"20","author":"Garc\u00eda-Criado","year":"2001","journal-title":"J Ultrasound Med"},{"key":"R15-18-20210211","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00007890-199711150-00011","article-title":"Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival","volume":"64","author":"Sheiner","year":"1997","journal-title":"Transplantation"},{"key":"R16-18-20210211","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/lt.24468","article-title":"Intention-to-treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation","volume":"22","author":"Rajakannu","year":"2016","journal-title":"Liver Transpl"},{"key":"R17-18-20210211","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jvs.2015.04.400","article-title":"Primary stent placement for hepatic artery stenosis after liver transplantation","volume":"62","author":"Le","year":"2015","journal-title":"J Vasc Surg"},{"key":"R18-18-20210211","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.transproceed.2011.08.028","article-title":"Treatment of early hepatic artery thrombosis after liver transplantation","volume":"43","author":"Grodzicki","year":"2011","journal-title":"Transplant Proc"},{"key":"R19-18-20210211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1538574411407088","article-title":"Endovascular therapy for hepatic artery stenosis and thrombosis following liver transplantation","volume":"45","author":"Sabri","year":"2011","journal-title":"Vasc Endovascular Surg"},{"key":"R20-18-20210211","first-page":"542","article-title":"Percutaneous endovascular therapeutic options in treating posttransplant hepatic artery thrombosis with the aim of salvaging liver allografts: our experience","volume":"14","author":"Pereira","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"R21-18-20210211","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lt.23874","article-title":"Etiology and management of hepatic artery thrombosis after adult liver transplantation","volume":"20","author":"Mourad","year":"2014","journal-title":"Liver Transpl"},{"key":"R22-18-20210211","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/ajt.12700","article-title":"Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure","volume":"14","author":"Allen","year":"2014","journal-title":"Am J Transplant"},{"key":"R23-18-20210211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14218\/JCTH.2014.00032","article-title":"Update on autoimmune hepatitis","volume":"3","author":"Liberal","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"R24-18-20210211","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"R25-18-20210211","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","author":"Schramm","year":"2010","journal-title":"Liver Transpl"},{"key":"R26-18-20210211","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R27-18-20210211","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/lt.24347","article-title":"Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States","volume":"22","author":"Reddy","year":"2016","journal-title":"Liver Transpl"},{"key":"R28-18-20210211","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl"},{"key":"R29-18-20210211","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"R30-18-20210211","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/bcp.12635","article-title":"Liver transplant associated with paracetamol overdose: results from the seven-country SALT study","volume":"80","author":"Gulmez","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R31-18-20210211","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/lt.21681","article-title":"The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies","volume":"15","author":"Simpson","year":"2009","journal-title":"Liver Transpl"},{"key":"R32-18-20210211","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/lt.21692","article-title":"Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database","volume":"15","author":"Mindikoglu","year":"2009","journal-title":"Liver Transpl"},{"key":"R33-18-20210211","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2008-1073117","article-title":"Acute liver failure due to drugs","volume":"28","author":"Fontana","year":"2008","journal-title":"Semin Liver Dis"},{"key":"R34-18-20210211","first-page":"8","article-title":"Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994).","volume":"1-","author":"Gahche","year":"2011","journal-title":"NCHS Data Brief"},{"key":"R36-18-20210211","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.27317","article-title":"Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network","volume":"60","author":"Navarro","year":"2014","journal-title":"Hepatology"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:24:57Z","timestamp":1750893897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201801000-00018"}},"subtitle":["Evolution of Characteristics and Outcomes of Status-1 Liver Transplantation"],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001967","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}